Conversely, in RA patients, decreased Gal-9/TIM-3 signaling has been observed since the expression levels of TIM–3 on CD4+ T cells were lower compared to those from healthy controls [38–40]. This evidence concerns the gene LGALS9 and rheumatoid arthritis.